Cases & Deals

  • Home
  • Practices
  • Celgene seeks patent protection for different oral formulations of 5-AZACYTIDINE

Share

Celgene seeks patent protection for different oral formulations of 5-AZACYTIDINE

January 2016

Client(s) Celgene Corporation

Jones Day is prosecuting applications and developing a patent portfolio on behalf of Celgene Corporation for oral formulations of 5-AZACYTIDINE.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.